Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 292670011000036116 | leuprorelin acetate 30 mg modified release injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 292671011000036111 | leuprorelin acetate 30 mg modified release injection, 30 mg syringe (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| leuprorelin acetate 30 mg modified release injection, syringe | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| leuprorelin acetate 30 mg modified release injection, syringe | Is a | leuprorelin | true | Inferred relationship | Some | ||
| leuprorelin acetate 30 mg modified release injection, syringe | has intended active ingredient | leuprorelin | true | Inferred relationship | Some | 988211006 | |
| leuprorelin acetate 30 mg modified release injection, syringe | has Australian BoSS | leuprorelin acetate | true | Inferred relationship | Some | 988211006 | |
| leuprorelin acetate 30 mg modified release injection, syringe | has manufactured dose form | modified release injection | true | Inferred relationship | Some | ||
| leuprorelin acetate 30 mg modified release injection, syringe | has unit of use | syringe | true | Inferred relationship | Some | 988211007 |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product unit of use reference set
FHIR